Article
Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.
Oncotarget - 12 Jan 2016
Gatalica Zoran, Vranic Semir, Ghazalpour Anatole, Xiu Joanne, Ocal Idris Tolgay, McGill John, Bender Ryan P, Discianno Erin, Schlum Aaron, Sanati Souzan, Palazzo Juan, Reddy Sandeep, Pockaj Barbara
Abstract excerpt
Malignant phyllodes tumor is a rare breast malignancy with sarcomatous overgrowth and with limited effective treatment options for recurrent and metastatic cases. Recent clinical trials indicated a potential for anti-angiogenic, anti-EGFR and immunotherapeutic approaches for patients with sarcomas, which led us to investigate these and other targetable pathways in malignant phyllodes tumor of the breast....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
